Showing 521 - 540 results of 102,992 for search '(( 50 ((ms decrease) OR (mean decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.61s Refine Results
  1. 521
  2. 522
  3. 523
  4. 524

    Selective downregulation of SR Ca<sup>2+</sup> handling proteins and decreased SR Ca<sup>2+</sup> uptake in TG mice hearts. by Mayilvahanan Shanmugam (691549)

    Published 2015
    “…For each atrial Ca<sup>2+</sup> uptake experiment, atria from four mice were pooled. n = 4 for each group. The V<sub>max</sub> of Ca<sup>2+</sup> uptake was obtained at pCa 5.5.…”
  5. 525

    Participants characteristics. by Sakiko Fukui (387048)

    Published 2025
    “…</p><p>Methods</p><p>Sixty-nine deceased older adults from five special nursing homes were studied over 3.5 years (January 2016 to June 2020). …”
  6. 526

    Data_Sheet_5_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu... by Yize Li (471459)

    Published 2022
    “…We demonstrated artesunate prevented PINP in a dose-dependent manner, while exerting a clear anti-hyperalgesic effect on already existing PINP. …”
  7. 527
  8. 528

    Numbers of all fractures, arranged in order of decreasing mean age and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age. by Camilla Bergh (9904522)

    Published 2020
    “…<p>Numbers of all fractures, arranged in order of decreasing mean age and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age.…”
  9. 529
  10. 530
  11. 531

    The <i>P[syt<sup>P-L</sup>]</i> mutation decreases the Ca<sup>2+</sup> affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

    Published 2017
    “…<p>(A) Mean EJP amplitudes from <i>+/-;P[syt<sup>WT</sup>]/+</i> (filled black circles) and <i>+/-;P[syt<sup>P-L</sup>]/+</i> (filled red circles) larvae at Ca<sup>2+</sup> levels ranging from 0.05 mM—5.0 mM. …”
  12. 532
  13. 533
  14. 534
  15. 535
  16. 536
  17. 537

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
  18. 538
  19. 539
  20. 540